← All trials
NCT02443922
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2015
- Primary completion
- Dec 1, 2015
- Completion date
- Dec 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- National Institutes of Health (NIH)Lead sponsor
- Johnson and JohnsonCollaborator
- MerckCollaborator
- TakedaCollaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- NovartisCollaborator
- PfizerCollaborator
- Eli LillyCollaborator
- Juvenile Diabetes Research FoundationCollaborator
- AmylinCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.